In colorectal cancer, lithium treatment was shown to enhance the therapeutic responsiveness to chemotherapeutic agents by suppressing the activity of PI3K/Akt, an upstream regulator of mTOR, by triggering autophagy initiation [15,16]. This evidence concerns the gene MTOR and colorectal cancer.